{"id":1951,"date":"2020-08-26T09:36:04","date_gmt":"2020-08-26T09:36:04","guid":{"rendered":"https:\/\/clinlabint.3wstaging.nl\/first-clinical-proof-of-principle-for-t-track-tb-for-detection-of-active-tuberculosis\/"},"modified":"2021-01-08T11:13:19","modified_gmt":"2021-01-08T11:13:19","slug":"first-clinical-proof-of-principle-for-t-track-tb-for-detection-of-active-tuberculosis","status":"publish","type":"post","link":"https:\/\/clinlabint.com\/first-clinical-proof-of-principle-for-t-track-tb-for-detection-of-active-tuberculosis\/","title":{"rendered":"First clinical proof of principle  for T-Track TB for detection of active tuberculosis"},"content":{"rendered":"<p>Effective diagnosis and treatment of tuberculosis (TB) is notoriously difficult and the incidence of drug-resistant strains is increasing. However, using T-cell based diagnostic test systems,&nbsp; Lophius Biosciences has achieved its first successfully concluded clinical Proof of Principle study with respect to detection of active TB using its novel T-Track TB test, which is based on the company\u2019s proprietary Reverse T Cell Technology (RT Technology). The clinical Proof of Principle was concluded in India with a cohort of 44 patients. Results demonstrated that the new TB test was able to detect active TB in in 10 of 12 non-treated patients. Besides its high sensitivity and specificity the test also demonstrated a remarkably short turnaround time of 2 days, which compares favourably to currently used detection methods. These results suggest that the T-Track TB test could represent an innovative and fast detection approach for this area of strong medical need.<\/p>\n<p><strong><link http:\/\/tinyurl.com\/cm6r8e4 _blank external-link-new-window>http:\/\/tinyurl.com\/cm6r8e4<\/link><\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Effective diagnosis and treatment of tuberculosis (TB) is notoriously difficult and the incidence of drug-resistant strains is increasing. However, using T-cell based diagnostic test systems,&nbsp; Lophius Biosciences has achieved its first successfully concluded clinical Proof of Principle study with respect to detection of active TB using its novel T-Track TB test, which is based on [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[35],"tags":[],"_links":{"self":[{"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/posts\/1951"}],"collection":[{"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/comments?post=1951"}],"version-history":[{"count":0,"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/posts\/1951\/revisions"}],"wp:attachment":[{"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/media?parent=1951"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/categories?post=1951"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/tags?post=1951"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}